Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
![(2R,4aR,7aS)-2-[(R)-hydroxy-(2-methoxyphenyl)methyl]-6-(naphthalen-1-ylmethyl)-1-(4-nitroanilino)-4a,7a-dihydro-2H-pyrrolo[3,4-b]pyridine-5,7-dione](https://www.pharmacompass.com/image/drug/153491237.png)
![(2R,4aR,7aS)-2-[(R)-hydroxy-(2-methoxyphenyl)methyl]-6-(naphthalen-1-ylmethyl)-1-(4-nitroanilino)-4a,7a-dihydro-2H-pyrrolo[3,4-b]pyridine-5,7-dione](https://www.pharmacompass.com/image/drug/153491237.png)
1. Chembl5939213
2. Bdbm553928
3. Us11325905, Compound A83b4c63
| Molecular Weight | 564.6 g/mol |
|---|---|
| Molecular Formula | C32H28N4O6 |
| XLogP3 | 5.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 128 |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 1020 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE